GENE S. CARTWRIGHT, PH.D. - Corporate Board Profile

GUIDED THERAPEUTICS INC

Filing Date	Source Excerpt
2014-05-13	Gene S. Cartwright, Ph.D. joined us in January 2014 as the President, Chief Executive Officer and Acting Chief Financial Officer. He was elected as a director on January 31, 2014.
2015-04-27	Gene S. Cartwright, Ph.D. joined us in January 2014 as the President, Chief Executive Officer and Acting Chief Financial Officer. He was elected as a director on January 31, 2014. ... Dr. Cartwright's 2014 compensation consisted of a base salary of $300,000, with $150,000 performance condition related bonus, and the usual customary company benefits. He also received 2,000,000 both market and performance condition restricted shares of common stock ... Dr. Cartwright was also issued 35,000 and 250,000 of stock options that vest over 48 months in 2014.
2015-07-31	By Order of the Board of Directors Gene S. Cartwright, Ph.D. President and Chief Executive Officer, Director Norcross, Georgia July 31, 2015
2015-10-14	Gene S. Cartwright, Ph.D. President and Chief Executive Officer, Director
2016-08-25	Gene S. Cartwright, Ph.D. joined us in January 2014 as the President, Chief Executive Officer and Acting Chief Financial Officer. He was elected as a director on January 31, 2014. ... Dr. Cartwright's 2015 and 2014 compensation consisted of a base salary of $300,000, with $150,000 performance condition related bonus, and the usual customary company benefits.
2018-09-17	Gene S. Cartwright, Ph.D. joined us in January 2014 as the President, Chief Executive Officer and Acting Chief Financial Officer. He was elected as a director on January 11, 2014. His most recent position was with Omnyx, LLC, a Joint Venture between GE Healthcare and the University of Pittsburgh Medical Center, where, as CEO for over four years he founded and managed the successful development of products for the field of Digital Pathology. Prior to his work with Omnyx, LLC, he was President of Molecular Diagnostics for GE Healthcare. Prior to GE, Dr. Cartwright was Divisional Vice President/General Manager for Abbott Diagnostics’ Molecular Diagnostics business. In his 24 year career at Abbott, he also served as Divisional Vice President for U.S. Marketing for five years. He received a Masters of Management degree from Northwestern’s Kellogg School of Management and also holds a Ph.D. in chemistry from Stanford University and an AB from Dartmouth College. Dr. Cartwright brings over 30 years of experience working in the IVD diagnostics industry. He has great experience in the diagnostics market both in the development and introduction of new diagnostics technologies, as well as extensive successful commercial experience with global businesses. With his background and experience, Dr. Cartwright, as President and Chief Executive Officer, as well as Acting Chief Financial Officer, works with and advises the Board as to how we can successfully market and build LuViva international sales.
2018-10-11	Gene S. Cartwright, Ph.D. (*), 64, Chief Executive Officer, President, Acting Chief Financial Officer and Director. For the fiscal years ended December 31, 2017 and 2016, none of our directors received any form of compensation.
2021-07-06	Gene S. Cartwright, Ph.D. joined us in January 2014 as the President, Chief Executive Officer and Acting Chief Financial Officer. He was elected as a director on January 11, 2014. ... For the fiscal years ended December 31, 2020 and 2019, none of our directors received any form of cash compensation. ... 2020 and 2019 Summary Compensation Table ... Gene S. Cartwright, Ph.D. President, CEO Acting CFO and Director ... Total ($) 205,200.